Concepedia

Ri Hong

RH

Statistics

Publications

4

Citations

159

H-Index

4

Active since

2012

Affiliations

Sanya City Women and Children Hospital(Current)

Zhejiang Chinese Medical University

Ri Hong is an author at Sanya City Women and Children Hospital specializing in medicine, oncology, and pharmacology.

Publications per year

2012–2021

4

Publications

4

The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer

Xiaohong Xie, Yuanyuan Hu, Leilai Xu et al. · Tumor Biology · 2015 · 60 citations

Medicine, Cancer Biology, Oncology +16

Inhibition of Breast Cancer Metastasis Via PITPNM3 by Pachymic Acid

Ri Hong, Minhe Shen, Xiaohong Xie et al. · Asian Pacific Journal of Cancer Prevention · 2012 · 35 citations · Full text

Medicine, Oncology, Pharmacology +17

Network Pharmacology–Based Identification of Key Mechanisms of Xihuang Pill in the Treatment of Triple-Negative Breast Cancer Stem Cells

Yuzhu Zhang, Jiayao Yang, Ruixian Wu et al. · Frontiers in Pharmacology · 2021 · 34 citations · Full text

Medicine, Oncology, Pharmacology +10

Selective inhibition of IDO1, D-1-methyl-tryptophan (D-1MT), effectively increased EpCAM/CD3-bispecific BiTE antibody MT110 efficacy against IDO1hibreast cancer via enhancing immune cells activity

Ri Hong, Yuhai Zhou, Xiujuan Tian et al. · International Immunopharmacology · 2017 · 30 citations

Medicine, Oncology, Pharmacology +16

1–4 of 4